ISSN: ISSN 2472-016X

整形外科腫瘍学ジャーナル

オープンアクセス

当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い

オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得

抽象的な

Role of Immunotherapy in Orthopedic Oncology: A Paradigm Shift in Cancer Treatment

Samar Kumar

Orthopedic oncology, the specialized field focusing on the management of bone and soft tissue tumors, has witnessed a remarkable shift in cancer treatment approaches with the emergence of immunotherapy. Immunotherapy utilizes the body’s immune system to recognize and attack cancer cells, offering a promising alternative to traditional treatment modalities. This short communication explores the evolving role of immunotherapy in orthopedic oncology and its transformative impact on cancer care. We discuss the principles behind immunotherapy, including immune checkpoint inhibitors, adoptive cell therapies, and cancer vaccines, and their specific applications in orthopedic malignancies. Furthermore, we examine the clinical advancements and ongoing research in the field, highlighting the potential of immunotherapy to improve patient outcomes and revolutionize cancer treatment strategies in orthopedic oncology. By embracing this paradigm shift, orthopedic oncologists can pave the way towards more effective and personalized therapeutic interventions, providing renewed hope for patients facing these challenging tumors.